This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20180629 PLA call"
Jump to navigation
Jump to search
(Created page with "{{subst:: PLA Template}}") |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 12: | Line 12: | ||
========================================================================---> | ========================================================================---> | ||
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/> | | colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/> | ||
| − | '''Location: ''' | + | '''Location: ''' <br/>https://global.gotomeeting.com/join/177894709 |
| − | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: | + | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018-06-29'''<br/> '''Time: 11:30 AM''' |
|- | |- | ||
| colspan="1" align="right"|'''Facilitator''' | | colspan="1" align="right"|'''Facilitator''' | ||
| Line 38: | Line 38: | ||
===============================================================================---> | ===============================================================================---> | ||
|- | |- | ||
| − | | || Calvin Beebe | + | | x|| Calvin Beebe |
|- | |- | ||
| − | | ||Lorraine Constable | + | |x ||Lorraine Constable |
|- | |- | ||
| || Jean Duteau, | | || Jean Duteau, | ||
| Line 48: | Line 48: | ||
| || Paul Knapp | | || Paul Knapp | ||
|- | |- | ||
| − | | || Austin Kreisler, | + | | x|| Austin Kreisler, |
|- | |- | ||
| − | | || Mary Kay McDaniel | + | | x|| Mary Kay McDaniel |
|- | |- | ||
| || Brian Pech | | || Brian Pech | ||
| Line 77: | Line 77: | ||
===Agenda=== | ===Agenda=== | ||
Agenda review | Agenda review | ||
| − | *Notes of [[ | + | *Notes of [[20180601_PLA_call]] review |
| + | *Action items | ||
| + | **MK will do some research and make a Confluence page for PLA | ||
| + | **Wayne will reach out to Stan to get his take on CIMI issues | ||
| + | **Lorraine to forward email regarding CIMI road map | ||
| + | **Paul to attend a few CIMI calls to assess the situation | ||
| + | **Anne to draft a call for V2MG international/payer participation | ||
| + | ***Complete; sent out last week | ||
*notional division of products into product families and lines, to provide examples for peer review. | *notional division of products into product families and lines, to provide examples for peer review. | ||
**Level of granularity | **Level of granularity | ||
| Line 87: | Line 94: | ||
===Minutes=== | ===Minutes=== | ||
| − | + | *Austin to send email to V2 and 2 CDA nominees | |
| − | + | *Set up first meeting for V2 | |
| − | + | *MK to find an agenda template that was used for CDAMG | |
| + | *Steps to establish a new product family | ||
| + | **SGB has been working on the decision making piece | ||
| + | **Review BAM Section 2 to make it more practical | ||
| + | **Section 1 is on how to determine if a product family is necessary | ||
| + | **Section 2: | ||
| + | ***Complete mission and charter | ||
| + | ***Identify and/or establish a management group - ensuring a balance of perspectives | ||
| + | ****PLA w/SGB puts together candidate slate | ||
| + | ***ID and establish methodology group | ||
| + | ***ID and establish content groups | ||
| + | ***Recommend to TSC for approval | ||
| + | ***Ensure they have appropriate level of relationship with support groups (tooling/publishing) | ||
| + | *Anne to ask Andrea/Pat to send reminder for V2 nominees | ||
| + | |||
===Meeting Outcomes=== | ===Meeting Outcomes=== | ||
| Line 119: | Line 140: | ||
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
| − | *[[ | + | *[[20180713 PLA call]] |
|} | |} | ||
| − | © | + | © 2018 Health Level Seven® International. All rights reserved |
Latest revision as of 14:11, 13 July 2018
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA Call Minutes |
Date: 2018-06-29 Time: 11:30 AM | ||
| Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
| Attendee | Name
| ||
| x | Calvin Beebe | ||
| x | Lorraine Constable | ||
| Jean Duteau, | |||
| Tony Julian | |||
| Paul Knapp | |||
| x | Austin Kreisler, | ||
| x | Mary Kay McDaniel | ||
| Brian Pech | |||
| Wayne Kubick | |||
| John Roberts | |||
| Andy Stechishin | |||
| no quorum definition | |||
Agenda
Agenda review
- Notes of 20180601_PLA_call review
- Action items
- MK will do some research and make a Confluence page for PLA
- Wayne will reach out to Stan to get his take on CIMI issues
- Lorraine to forward email regarding CIMI road map
- Paul to attend a few CIMI calls to assess the situation
- Anne to draft a call for V2MG international/payer participation
- Complete; sent out last week
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
- Austin to send email to V2 and 2 CDA nominees
- Set up first meeting for V2
- MK to find an agenda template that was used for CDAMG
- Steps to establish a new product family
- SGB has been working on the decision making piece
- Review BAM Section 2 to make it more practical
- Section 1 is on how to determine if a product family is necessary
- Section 2:
- Complete mission and charter
- Identify and/or establish a management group - ensuring a balance of perspectives
- PLA w/SGB puts together candidate slate
- ID and establish methodology group
- ID and establish content groups
- Recommend to TSC for approval
- Ensure they have appropriate level of relationship with support groups (tooling/publishing)
- Anne to ask Andrea/Pat to send reminder for V2 nominees
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2018 Health Level Seven® International. All rights reserved
